These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3521163)

  • 1. [Biology of the causative agent of melioidosis].
    Riapis LA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):96-100. PubMed ID: 3521163
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigenic composition and the serological diagnosis of Pseudomonas pseudomallei].
    Kovalev GK
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):109-17. PubMed ID: 2412369
    [No Abstract]   [Full Text] [Related]  

  • 3. [The nature of changes in the antigenic spectrum of the causative agent of melioidosis during animal passage].
    Peters MK; Piven' NN; Iliukhin VI; Barkov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):47-50. PubMed ID: 6415970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic structure and serology of the pseudomonads].
    Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 1986 May; (5):88-93. PubMed ID: 2425517
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ecological and biological maintenance of sapronoses exemplified by melioidosis].
    Larionov GM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):36-40. PubMed ID: 3389005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The agent of melioidosis (review of the literature)].
    Efimtseva EP; Ermol'eva ZV; Stosser L
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):38-44. PubMed ID: 4218027
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and outlook for the study of live vaccines for the prevention of melioidosis].
    Iliukhin VI; Kislichkin NN; Merinova LK; Riapis LA; Denisov II; Farber SM; Kislichkina OI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):49-51. PubMed ID: 10356737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic structure of the causative agent of melioidsis and its cellular structures].
    Efimtseva EP; Shtesser LG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):29-32. PubMed ID: 4212546
    [No Abstract]   [Full Text] [Related]  

  • 11. [Identification of cell structure antigens of the causative agent of melioidosis by a 2-dimensional immunoelectrophoresis method].
    Alekseev VV; Kaleĭ GM; Loktionov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):62-5. PubMed ID: 6702362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ecological aspects of Pseudomonas pseudomallei interactions with ixodid ticks].
    Kharbov D; Velianov D; Raucheva T
    Acta Microbiol Bulg; 1981; 8():17-24. PubMed ID: 7340413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phagocytability of Pseudomonas pseudomallei].
    Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):130-2. PubMed ID: 665019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Capsule formation by the causative agent of melioidosis in the body].
    Mel'nikov BI; Popov SF; Iakovlev AT; Denisov II; Bozhko VG; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):6-10. PubMed ID: 2256403
    [No Abstract]   [Full Text] [Related]  

  • 15. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
    Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
    J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.
    Burtnick MN; Shaffer TL; Ross BN; Muruato LA; Sbrana E; DeShazer D; Torres AG; Brett PJ
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109172
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.
    Nelson M; Prior JL; Lever MS; Jones HE; Atkins TP; Titball RW
    J Med Microbiol; 2004 Dec; 53(Pt 12):1177-1182. PubMed ID: 15585494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenic potential of glanders and melioidosis agents].
    Kalachev II; Baídus' AN; Ivanova OA; Ganina EA; Boldyrev IA; Svetoch EA
    Vestn Ross Akad Med Nauk; 1997; (6):32-7. PubMed ID: 9289277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The outlook for the development of live vaccines for the prevention of melioidosis].
    Iliukhin VI; Kislichkin NN; Merinova LK; Riapis LA; Denisov II; Farber SM; Kislichkina OI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):52-5. PubMed ID: 10851991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The polysaccharide component of Pseudomonas pseudomallei slime].
    Denisov II
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):23-6. PubMed ID: 2418606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.